Evidence for an endothelial cell dysfunction in association with Behçet's disease

Area of Science:

• Vascular Biology
• Hematology
• Immunology

Background:

• Behçet's disease (BD) is characterized by fibrinolytic system suppression, linked to impaired vascular endothelial function.
• Previous studies suggest endothelial cell dysfunction in BD, indicated by diminished platelet factor 4 release.
• Understanding the hemostatic abnormalities in BD is crucial for managing thrombotic complications.

Purpose of the Study:

• To investigate the impact of DDAVP (desmopressin) infusion on fibrinolytic activity and endothelial markers in BD patients.
• To assess endothelial cell function and hemostatic abnormalities in Behçet's disease.

Main Methods:

• 12 BD patients and 10 healthy volunteers received DDAVP infusions.
• Euglobulin clot lysis time, factor VIII activities (F.VIII R:Ag and F. VIII:C), and 6-keto-PGF1 alpha levels were measured pre- and post-infusion.
• Comparative analysis between BD patients and controls was performed.

Main Results:

• Euglobulin clot lysis time was significantly prolonged in BD patients post-DDAVP infusion.
• Levels of F.VIII R:Ag were lower in BD patients compared to controls after DDAVP.
• F. VIII:C activity increased in both groups, while 6-keto-PGF1 alpha levels remained unchanged in all subjects.

Conclusions:

• Disseminated endothelial tissue damage in BD correlates with multiple endothelial cell dysfunctions.
• These dysfunctions lead to significant hemostatic abnormalities, including impaired fibrinolysis.
• The findings highlight the link between endothelial dysfunction and thrombotic risk in Behçet's disease.